With larger quantities of the global population living longer than ever before, arthritis already affects an estimated 350 million people worldwide. It is a disease that has debilitating effects on the health and quality of life of its surreferes. While there are a significant number of arthritis treatments available on the market, there are also many less-explored therapeutic areas for innovators to pursue, and investment in this area shows no sign of slowing down.
Pharmaceutical manufacturers looking to focus their research and development (R&D) in the treatment of arthritis must be fully aware of this drug discovery landscape. Understanding which therapeutic areas are having more patents filed, which geographic territories are being targeted by competitors, which are the key players in this space nad which are the new contenders will be instrumental in determining a long-term, successful innovation strategy.
This PatSnap report investigates these topics and more, providing a 360 degree view into the innovation landscape for the treatment of arthritis, identifying the market opportunities available to innovators in this area.
This technology report is written in collaboration with GreyB.
The PatSnap platform helps you spend less time and money, getting the answers you need to increase returns on your investment in innovation.
To request your customised demo, simply fill out the form and a helpful expert will be in touch.